RTW Investments Updates Allurion Technologies Stake

TL;DR

RTW Investments just filed an update on their Allurion Technologies stake. Watch this space.

AI Summary

RTW Investments, LP, through an amendment filed on October 24, 2024, has updated its beneficial ownership of Allurion Technologies, Inc. The filing indicates a change in the reporting person's holdings, though specific new dollar amounts or exact share counts are not detailed in this excerpt. The amendment pertains to the Schedule 13D/A filing.

Why It Matters

This filing signals a potential shift in major shareholder activity for Allurion Technologies, Inc., which could influence stock price and corporate strategy.

Risk Assessment

Risk Level: medium — Schedule 13D/A filings often indicate significant changes in ownership by large investors, which can lead to increased volatility.

Key Players & Entities

• RTW Investments, LP (company) — Reporting Person
• Allurion Technologies, Inc. (company) — Subject Company
• Roderick Wong, M.D. (person) — Contact Person for RTW Investments

FAQ

Key Financial Figures

• $0.0001 — me of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securitie

Filing Documents

• p24-3055sc13da.htm (SC 13D/A) — 36KB
• 0000902664-24-005972.txt ( ) — 38KB

Purpose of Transaction

Item 4. Purpose of Transaction.

of the Schedule 13D is hereby amended

Item 4 of the Schedule 13D is hereby amended to add the following: On October 22, 2024, certain RTW Funds provided notice to the Company of their election under the RTW Side Letter, as amended, to surrender 749,998 Shares in consideration for the Additional Revenue Interest Financing Agreement, as contemplated in the RTW Side Letter. Those certain RTW Funds provided irrevocable instructions for the surrender of such shares on October 22, 2024. Accordingly, the Shares of the Company beneficially held by the RTW Funds reported herein has been reduced by 749,998 Shares to reflect the surrender of such shares pursuant to the RTW Side Letter.

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer. Items 5(a)-(c) are hereby amended and restated as follows: (a) The aggregate percentage of Shares reported to be beneficially owned by the Reporting Persons is based upon 64,338,421 Shares which is the difference obtained by subtracting (x) the 749,998 Shares surrendered to the Company as reported herein in Item 4 from (x) the 64,369,381 Shares reported to be outstanding as of September 23, 2024, as disclosed in the Company's Prospectus filed pursuant to Rule 424(b)(5) with the Securities and Exchange Commission on October 7, 2024, and assumes the conversion of the Notes up to the Conversion Cap (as defined in Item 4 of Amendment No. 1) and the exercise of the Public Warrants and no conversion of the Series A Preferred Stock or exercise of the Private Warrants. The Public Warrants held by the RTW Funds are days' prior notice and accordingly, the Reporting Persons have included the Shares issuable upon exercise of Public Warrants as if the Blocker was set to 9.99%. (b) See rows (7) through (10) of the cover page to this Amendment No. 3 for the number of Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. (c) The Reporting Persons did not effect any transactions with respect to the Shares during the past sixty (60) days other than as reported in Item 4. CUSIP No. 02008G102 13D/A Page 5 of 5 Pages

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct. Date: October 24, 2024 RTW INVESTMENTS, LP By: /s/ Roderick Wong, M.D. Name: Roderick Wong, M.D. Title: Managing Partner /s/ Roderick Wong, M.D. RODERICK WONG, M.D.

View Full Filing

View this SC 13D/A filing on SEC EDGAR